Kangmei Pharmaceutical Co., Ltd. (600518.SS)
- Previous Close
1.9100 - Open
1.9100 - Bid 1.9200 x --
- Ask 1.9300 x --
- Day's Range
1.9000 - 1.9400 - 52 Week Range
1.6800 - 2.5000 - Volume
71,698,469 - Avg. Volume
120,022,229 - Market Cap (intraday)
26.757B - Beta (5Y Monthly) 0.72
- PE Ratio (TTM)
193.00 - EPS (TTM)
0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 28, 2019
- 1y Target Est
--
Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. It also offers chemical medicines and health food; and operates hospitals and pharmacies. Kangmei Pharmaceutical Co., Ltd. was founded in 1997 and is headquartered in Shenzhen, China.
www.kangmei.com.cn4,409
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: 600518.SS
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600518.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600518.SS
Valuation Measures
Market Cap
26.48B
Enterprise Value
25.68B
Trailing P/E
191.00
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.02
Price/Book (mrq)
3.76
Enterprise Value/Revenue
5.27
Enterprise Value/EBITDA
50.08
Financial Highlights
Profitability and Income Statement
Profit Margin
2.10%
Return on Assets (ttm)
0.87%
Return on Equity (ttm)
1.47%
Revenue (ttm)
4.87B
Net Income Avi to Common (ttm)
102.52M
Diluted EPS (ttm)
0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
1.06B
Total Debt/Equity (mrq)
3.60%
Levered Free Cash Flow (ttm)
-278.02M
Research Analysis: 600518.SS
Company Insights: 600518.SS
600518.SS does not have Company Insights